Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial - Cudkowicz, ME; van den Berg, LH; Shefner, JM (The Lancet Neurology, 2013)